Walgreens Boots Alliance (NASDAQ:WBA) Given New $12.00 Price Target at Truist Financial

Walgreens Boots Alliance (NASDAQ:WBA) had its price target decreased by Truist Financial from $13.00 to $12.00 in a report issued on Friday,Benzinga reports. Truist Financial currently has a hold rating on the pharmacy operator’s stock.

A number of other brokerages have also recently commented on WBA. TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Evercore ISI raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Finally, Jefferies Financial Group reduced their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Stock Down 10.3 %

NASDAQ:WBA opened at $10.28 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company’s fifty day moving average price is $10.09 and its 200-day moving average price is $9.88. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $23.76. The firm has a market capitalization of $8.88 billion, a P/E ratio of -1.00, a PEG ratio of 1.41 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the business posted $0.66 EPS. The company’s revenue was up 7.6% on a year-over-year basis. As a group, equities research analysts anticipate that Walgreens Boots Alliance will post 1.6 EPS for the current year.

Institutional Investors Weigh In On Walgreens Boots Alliance

Large investors have recently modified their holdings of the business. State Street Corp boosted its position in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after acquiring an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after purchasing an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC boosted its holdings in shares of Walgreens Boots Alliance by 15.5% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares during the last quarter. Finally, FMR LLC grew its position in shares of Walgreens Boots Alliance by 2.5% in the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock valued at $29,200,000 after purchasing an additional 80,525 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.